Xilio Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.58

+0.31 (+3.34%)

As of Jun 30, 10:43 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +421.3% upside

Low Target $27.43

Average Target $49.94

High Target $65.11

Current Price $9.58

Current
$9.58

Target
$49.94

$27.43 $49.94 avg $65.11

Scenario Analysis

Bear Case

$27.43

186.3%

Low target

Base Case

$49.94

+421.3%

Avg target

Bull Case

$65.11

+579.6%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$12.74

-24.8% from high

52-Week Low

$6.47

+48.1% from low

Target vs 52W High

$49.94

+292.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%